BridgeMD
New treatment option for Embolic Stroke of Undetermined Source
Official title Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause
ClinicalTrials.gov ID: NCT07295769
What this study is testing
- What it's testing
- The purpose of this study is to evaluate the efficacy and safety of a wearable device in detecting previously undiagnosed atrial fibrillation through non-invasive long-term monitoring using a wearable single-lead ECG patch (MEMO Patch M, MEMO Patch2) in 100 patients with Embolic Stroke of Undetermined Source (ESUS) who require atrial fibrillation screening. Participants who meet all inclusion and exclusion criteria and provide written informed consent will wear the MEMO Patch M and undergo in-hospital telemetry monitoring using MEMO Cue for a minimum of 12 hours and up to 8 days.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Participants may take part in this clinical study only if they meet all of the following criteria:
- Adults aged 19 years or older who voluntarily provide written informed consent to participate in the study
- Patients diagnosed with ESUS (Embolic Stroke of Undetermined Source)
- Patients who require in-hospital or out-of-hospital electrocardiographic (ECG) monitoring
You likely can't join if
- Participants who meet any of the following criteria cannot be enrolled in this clinical study:
- Individuals already diagnosed with atrial fibrillation or atrial flutter
- Individuals with a clearly identified cause of stroke
- Individuals known to have allergic reactions to adhesives or hydrogels
- Individuals who, in the investigator's judgment, have cognitive vulnerability that makes it difficult to understand the study information and...
- Any other individuals whom the principal investigator considers to be at potential risk by participating in the study or otherwise unsuitable for...
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Songpa-gu, South Korea
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Songpa-gu, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.